Literature cited
L. Ya. Binduka, I. K. Shprunka, Ya. A. Benders, and R. A. Zhagat, Bioorg. Khim.,6, No. 10, 1549–1553 (1980).
R. A. Zhagat, I. K. Shprunka, I. A. éidus, et al., Izv. Akad. Nauk Latv. SSR, Ser. Khim., No. 1, 73–76 (1972).
I. K. Shprunka, L. Ya. Binduka, T. V. Shidlovskaya, and R. A. Zhagat, Khim. Prirod. Soedin., No. 2, 232–235 (1980).
R. N. Adamson and S. Farbo, Cancer Chem. Rep.,52, No. 6, 617–626 (1968).
R. L. Capizzi and R. E. Handschumaker, Cancer Medicine, Philadelphia (1973), p. 850.
R. E. Handschumaker, Cancer Res.,29, No. 12, 2466–2468 (1969).
R. E. Handschumaker, Colloq. Int. C. N. R. S., No. 197, 377–386 (1971).
R. E. Handschumaker and C. Gaumond, Molec. Pharmacol.,8, No. 1, 59–64 (1972).
L. E. Hare and R. E. Handschumaker, ibid.,9, No. 4, 534–541 (1973).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. Chem.,193, No. 1, 265–275 (1951).
H. Makino, H. Saton, Y. Kuroiwa, et al., Immunochemistry,12, No. 2, 183–185 (1975).
Y. Nishimura, H. Makino, O. Takenaka, and Y. Inada, Biochim. Biophys. Acta; Enzymology,227, No. 1, 171–179 (1971).
J. Pütter and G. Gehrmann, Klin. Wochenschr.,47, No. 24, 1324–1326 (1969).
J. F. Riordan and B. L. Vallee, Meth. Enzymol.,25, Pt. B, 494–499 (1972).
H. M. Suld and P. A. Herbut, J. Biol. Chem.,245, No. 11, 2802–2808 (1970).
O. Wagner, E. Irion, A. Arens, and K. Bauer, Biochem. Biophys. Res. Commun.,37, No. 3, 383–392 (1969).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 22, No. 1, pp. 32–34, January, 1988.
Rights and permissions
About this article
Cite this article
Shprunka, I.K., Dauvarte, A.Z., Veksler, K.M. et al. Drugs derived from modified L-asparaginase. Pharm Chem J 22, 23–25 (1988). https://doi.org/10.1007/BF00759050
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00759050